AMY LEEZER: Open Payments
NPI 1487190641 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 9 payments from 6 companies in 2025. Trend: 2023 $1,030 · 2024 $646 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| ABIOMED | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| PFIZER INC. | 1 | $15 |
Products named: JARDIANCE, EVKEEZA, LEQVIO, Ozempic, ENTRESTO, ELIQUIS.
Industry payments across IN — which companies pay providers there.
